Moghat, the roots of Glossostemon bruguieri (Desf.) as a nutraceutical against metabolic syndrome through PI3K/AKT/mTOR and TLR4–MYD88–p38 MAPK pathways
Journal of Pharmacy and Pharmacology · 2026
DOI: 10.1093/jpp/rgag123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Salma Mostafa Mohamed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt. Hauptthemen laut MEDLINE: Metabolic Syndrome, Plant Extracts. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Objectives
This research was designed to assess the impact and underlying pathways of the root aqueous extract of Moghat root (MRE) on metabolic syndrome (MS).
Methods
The extract’s constituents were identified through HPLC analysis, followed by evaluation of its impact on lipid and glucose metabolism using in vitro and in vivo assays. Key findings In a high-fat high-carbohydrate diet, streptozotocin animal model-induced MS, MRE increased fat accumulation and diminished the genes expression included in lipogenesis. Moreover, the extract enhanced obesity, the resistance of insulin, the amounts of lipid, oxidative stress, and hepatic function in MS rats after a 4 weeks intervention orally with the extract at 100 and 200 mg/kg related to metformin at 200 mg/kg after verification of diabetes. MRE decreased the expression of hepatic INSR, Srebf1, mTOR, PI3K, AKT, NF-κβ, and IL-6 through the PI3K/AKT/mTOR signaling pathway to inhibit inflammation and lipid accumulation and achieve its hypolipidemic effect. Moreover, MRE decreased the expression of MYD88 and p38 MAPK which was confirmed in liver tissue by using IHC analysis.
Conclusions
Our data proposed that MRE could improve MS by improving lipid metabolism via numerous pathways and can be progressed into dietary supplements for the correction of MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
- Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
- Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Cairo 12211, Egypt.
ORCID-Profile: Salma Mostafa Mohamed, Riham A El-Shiekh, Maha M Rashad, Shaimaa Kamel, Alaa F Bakr
Zitieren
APA
Mostafa Mohamed, S., El-Shiekh, R. A., Rashad, M. M., Kamel, S., & Bakr, A. F. (2026). Moghat, the roots of Glossostemon bruguieri (Desf.) as a nutraceutical against metabolic syndrome through PI3K/AKT/mTOR and TLR4–MYD88–p38 MAPK pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag123
Vancouver
Mostafa Mohamed S, El-Shiekh RA, Rashad MM, Kamel S, Bakr AF. Moghat, the roots of Glossostemon bruguieri (Desf.) as a nutraceutical against metabolic syndrome through PI3K/AKT/mTOR and TLR4–MYD88–p38 MAPK pathways. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag123
BibTeX
@article{MostafaMohamed2026,
author = {Mostafa Mohamed, Salma and El-Shiekh, Riham A and Rashad, Maha M and Kamel, Shaimaa and Bakr, Alaa F},
title = {Moghat, the roots of Glossostemon bruguieri (Desf.) as a nutraceutical against metabolic syndrome through PI3K/AKT/mTOR and TLR4–MYD88–p38 MAPK pathways},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
doi = {10.1093/jpp/rgag123}
}
EUVIMED